Company Overview of Novopyxis Inc.
Novopyxis Inc., a biotechnology company, develops novel anti-inflammatory therapeutics and interventions. It focuses on treatment for neurological and metabolic conditions which result from complications related to inflammatory issues ranging from ALS to cystic fibrosis and more. The company was founded in 2013 and is based in Boston, Massachusetts.
41 Winter Street
Boston, MA 02108
Founded in 2013
Key Executives for Novopyxis Inc.
Novopyxis Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
April 24, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Novopyxis Inc., please visit www.novopyxis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.